MAP2K2 and cancer: For this purpose, we transiently overexpressed WT-MEK1 and MEK2, the Q56P-MEK1, Y130C-MEK1, Q60P-MEK2 and Y134C-MEK2, as well as the cancer related K57N-MEK1 constructs, in COS7 or HeLa cells.